Cytomx analysts
WebMar 29, 2024 · So there's been quite a change-up of views after the recent consensus updates, with the analysts making a serious cut to their revenue forecasts while also expecting losses per share to increase. Check out our latest analysis for CytomX Therapeutics . NasdaqGS:CTMX Earnings and Revenue Growth March 29th 2024 WebApr 14, 2024 · CytomX Therapeutics, Inc. (NASDAQ:CTMX) Receives Average Rating of “Hold” from Analysts Globe Life (NYSE:GL) PT Lowered to $129.00 Morgan Stanley Lowers ICL Group (NYSE:ICL) Price Target to $7.50
Cytomx analysts
Did you know?
WebApr 14, 2024 · CytomX Therapeutics, Inc. (NASDAQ:CTMX - Get Rating) has received an average rating of "Hold" from the twelve analysts that are covering the firm, Marketbeat reports.One equities research analyst has rated the stock with a sell recommendation, nine have given a hold recommendation and two have assigned a buy recommendation to the …
WebMar 20, 2024 · CytomX Therapeutics Price Performance. Shares of NASDAQ:CTMX opened at $1.86 on Monday. The company has a market capitalization of $122.91 million, a price-to-earnings ratio of -1.25 and a beta of ... WebApr 14, 2024 · CytomX Therapeutics, Inc. (NASDAQ:CTMX – Get Rating) has been assigned a consensus recommendation of “Hold” from the twelve analysts that are presently covering the stock, Marketbeat reports.
WebApr 9, 2024 · 8 Analysts CTMX Stock Overview CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. About the company Risk Analysis Negative shareholders equity Currently unprofitable and not forecast to become profitable over the next 3 years See All Risk Checks My Notes WebWhat are analysts forecasts for CytomX stock? The 16 analysts offering price forecasts for CytomX have a median target of 6.42, with a high estimate of 16.00 and a low estimate …
WebCytomX Therapeutics Inc. analyst estimates, including CTMX earnings per share estimates and analyst recommendations.
WebApr 13, 2024 · We will contrast the two businesses based on the strength of their dividends, risk, earnings, institutional ownership, profitability, valuation and analyst … phoenix az permit searchWebApr 14, 2024 · Analysts at StockNews.com initiated coverage on shares of DAVIDsTEA ( NASDAQ:DTEA – Get Rating) in a research report issued to clients and investors on Friday. The brokerage set a “hold” rating... t test downloadWebMar 31, 2024 · CytomX Therapeutics, Inc. (NASDAQ:CTMX– Get Rating) – Stock analysts at HC Wainwright raised their Q1 2024 earnings per share estimates for CytomX Therapeutics in a report released on... phoenix az population historyWebCytomX Therapeutics Stock (NASDAQ:CTMX), Analyst Ratings, Price Targets, Predictions. Analysts publish ratings and price targets on most stocks. Benzinga tracks … t-test each time stepWebApr 6, 2024 · Find the latest CytomX Therapeutics, Inc. (CTMX) stock analysis from Seeking Alpha’s top analysts: exclusive research and insights from bulls and bears. t-test fitness testWebCompany Type For Profit. Phone Number 6503510353. CytomX Therapeutics is a biotechnology company that focuses on developing proteolytically-activated antibodies. … phoenix az population growth usaWebBased on analysts offering 12 month price targets for CTMX in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . t test feature selection